deaths in pfizer arthritis trial hurt shares
new data raising safety concerns for pfizer inc's experimental arthritis drug sent its shares down 3 percent, while lifting shares of rival drugmaker abbott laboratories, analysts said.
http://feeds.reuters.com/~r/reuters/healthnews/~3/q29wivx8xkm/us-pfizer-arthritis-idustre73k7h320110421
1425
22 Apr 2011 01:56:14
reuters
health